When compared with previous signatures (43–48), some genes in the signature, such AURKA, LCAT and ACOT12, were also identified as hub genes in predicting survival outcomes of HCC patients, in agreement with our study. This evidence concerns the gene AURKA and hepatocellular carcinoma.